Leqvio (Inclisiran) Dosing in Black and African Ancestry Patients: What the Evidence Actually Shows
A clinician-focused review of inclisiran pharmacokinetics, subgroup efficacy data, pharmacogenomic considerations, and dose-adjustment guidance for Black and African ancestry patients receiving Leqvio for LDL-C lowering.
Read clinical review